文献速递乳房整形与再造美容整形

Mentor Contour Profile Gel假体:10年临床结局

Mentor Contour Profile Gel Implants: Clinical Outcomes at 10 Years.
PubMed 文献 · Plast Reconstr Surg · 2017-01-01

这项前瞻性、开放标签、多中心临床研究纳入955名女性,评估Contour Profile Gel/MemoryShape乳房假体在初次隆乳、初次乳房再造及修正手术中的安全性和有效性。10年累积发生率显示,初次隆乳组Baker III/IV级包膜挛缩为3.6%,感染为0.7%,任何再手术为22.3%。结论认为该假体对至少22岁女性的初次及修正隆乳和乳房再造安全有效。

要点

  • 初次隆乳组10年Baker III/IV级包膜挛缩累积发生率为3.6%,修正隆乳组为15.5%。
  • 初次隆乳组10年任何再手术累积发生率为22.3%,初次乳房再造组为52.7%。
  • 初次隆乳组10年感染累积发生率为0.7%,修正乳房再造组为2.9%。

核心结论

  • 结果表明Contour Profile Gel/MemoryShape乳房假体对至少22岁女性的初次及修正隆乳和乳房再造安全有效。

研究设计与样本

  • 前瞻性、开放标签、多中心临床研究,纳入955名女性受试者,包括初次隆乳572例、修正隆乳124例、初次乳房再造190例、修正乳房再造69例。
  • 安全性基于所有并发症的发生率、严重程度和处理方法评估,终点按受试者和按假体两种方式分析。

主要发现

  • 受试者水平Kaplan-Meier估计10年累积发生率:Baker III/IV级包膜挛缩,初次隆乳3.6%、修正隆乳15.5%、初次乳房再造14.3%、修正乳房再造16.4%。
  • 感染发生率:初次隆乳0.7%、修正隆乳1.9%、初次乳房再造1.6%、修正乳房再造2.9%。
  • 取出假体(伴或不伴更换)发生率:初次隆乳9.2%、修正隆乳25.9%、初次乳房再造34.1%、修正乳房再造49.0%。
  • 取出假体并更换研究假体发生率:初次隆乳4.0%、修正隆乳10.8%、初次乳房再造16.7%、修正乳房再造27.9%。
  • 任何再手术发生率:初次隆乳22.3%、修正隆乳35.0%、初次乳房再造52.7%、修正乳房再造59.7%。

关键数值与推荐

  • 关键并发症终点按受试者水平以Kaplan-Meier法估计10年累积发生率。
  • Baker III/IV级包膜挛缩、感染、取出假体、取出并更换研究假体、任何再手术均按四个队列分别报告。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Contour Profile Gel/MemoryShape breast implants consist of a textured silicone elastomer shell filled with silicone gel. The objective of this clinical study was to assess the safety and effectiveness of Contour Profile Gel/MemoryShape breast implants in women who were undergoing primary breast augmentation, primary breast reconstruction, or revision surgery (revision-augmentation or revision-reconstruction). METHODS: This was a prospective, open-label, multicenter clinical study involving Contour Profile Gel/MemoryShape breast implants in 955 female subjects, including 572 primary augmentation, 124 revision-augmentation, 190 primary reconstruction, and 69 revision-reconstruction subjects. Safety was assessed based on the incidence, severity, and method of resolution of all complications. Endpoints were examined on both a per-subject and a per-implant basis. RESULTS: For the primary augmentation, revision-augmentation, primary reconstruction, and revision-reconstruction cohorts, the Kaplan-Meier estimated 10-year cumulative incidence rates for the key complications at the subject level were as follows: Baker grade III/IV capsular contracture, 3.6 (primary augmentation), 15.5 (revision-augmentation), 14.3 (primary reconstruction), and 16.4 (revision-reconstruction) percent; infection, 0.7 (primary augmentation), 1.9 (revision-augmentation), 1.6 (primary reconstruction), and 2.9 (revision-reconstruction) percent; explantation with or without replacement, 9.2 (primary augmentation), 25.9 (revision-augmentation), 34.1 (primary reconstruction), and 49.0 (revision-reconstruction) percent; explantation with replacement with study device, 4.0 (primary augmentation), 10.8 (revision-augmentation), 16.7 (primary reconstruction), and 27.9 (revision-reconstruction) percent; and any reoperation, 22.3 (primary augmentation), 35.0 (revision-augmentation), 52.7 (primary reconstruction), and 59.7 (revision-reconstruction) percent. CONCLUSION: The results of this study demonstrate that Contour Profile Gel/MemoryShape breast implants are safe and effective for primary and revision breast augmentation and reconstruction for women at least 22 years old.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Hammond DC, Canady JW, Love TR, et al. Mentor Contour Profile Gel Implants: Clinical Outcomes at 10 Years. Plast Reconstr Surg. 2017. PMID: 29176413. doi:10.1097/PRS.0000000000003846

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。